Conference call and webcast to begin after markets close at 2:00 p.m. PT
(5:00 p.m. ET)
IRVINE, Calif., July 18 /PRNewswire-FirstCall/ -- Masimo Corporation
(Nasdaq: MASI), the inventor of Pulse CO-Oximetry and
Measure-Through-Motion-and-Low-Perfusion pulse oximetry, today announced it
will release second quarter financial results for the period ended
June 28, 2008 after the market closes on Monday, August 4, 2008.
A conference call to review the results will begin at 2:00 p.m. PT
(5:00 p.m. ET) and will be hosted by Joe E. Kiani, Chairman and Chief
Executive Officer, and Mark P. de Raad, Executive Vice President and Chief
Financial Officer.
A live webcast of the conference call will be available online from the
investor relations page of the Company's corporate web site at
http://www.masimo.com. The dial-in numbers are (866) 356-3095 for domestic
callers and (617) 597-5391 for international callers. The reservation number
for both dial-in numbers is 90085495. After the live webcast, the call will
remain available on Masimo's website through September 4, 2008. In addition, a
telephonic replay of the call will be available until August 18, 2008. The
replay dial-in numbers are (888) 286-8010 for domestic callers and
(617) 801-6888 for international callers. Please use reservation code
86583404.
About Masimo
Masimo (NASDAQ: MASI) develops innovative monitoring technologies that
significantly improve patient care-helping solve "unsolvable" problems. In
1995, the company debuted Measure-Through-Motion-and-Low-Perfusion pulse
oximetry, known as Masimo SET, which virtually eliminated false alarms and
increased pulse oximetry's ability to detect life-threatening events. More
than 100 independent and objective studies demonstrate Masimo SET provides the
most reliable SpO2 and pulse rate measurements even under the most challenging
clinical conditions, including patient motion and low peripheral perfusion. In
2005, Masimo introduced Masimo Rainbow SET, a breakthrough noninvasive blood
constituent monitoring platform that can measure many blood constituents that
previously required invasive procedures. Rainbow SET continuously and
noninvasively measures total hemoglobin (SpHb(TM)), oxygen content (SpOC(TM)),
carboxyhemoglobin (SpCO(R)), methemoglobin (SpMet(R)), and PVI(TM), in
addition to oxyhemoglobin (SpO2), pulse rate (PR), and perfusion index (PI),
allowing early detection and treatment of potentially life-threatening
conditions. Founded in 1989, Masimo has the mission of "Improving Patient
Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New
Sites and Applications." Additional information about Masimo and its products
may be found at http://www.masimo.com.
Investor Contact:
Mark P. de Raad
Executive Vice President and Chief Financial Officer
(949) 297-7080
mderaad@masimo.com
Media Contact:
Dana Banks
(949) 297-7348
dbanks@masimo.com
SOURCE Masimo Corporation